American International Group, Inc. Denali Therapeutics Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$15.83 - $23.35 $1,931 - $2,848	122 Added 0.21%	58,847 $1.21 Million
Q4 2023 Feb 13, 2024	SELL	$16.2 - $23.18 $3,839 - $5,493	-237 Reduced 0.4%	58,725 $1.26 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $43,240 - $63,236	2,096 Added 3.69%	58,962 $1.22 Million
Q2 2023 Aug 04, 2023	BUY	$23.37 - $32.96 $101,332 - $142,914	4,336 Added 8.25%	56,866 $1.68 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $22,917 - $34,172	1,046 Added 2.03%	52,530 $1.21 Million
Q4 2022 Feb 10, 2023	BUY	$26.28 - $33.92 $123,699 - $159,661	4,707 Added 10.06%	51,484 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $17,166 - $25,468	661 Added 1.43%	46,777 $1.44 Million
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $19,731 - $33,254	945 Added 2.09%	46,116 $1.36 Million
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $92,191 - $150,271	-3,179 Reduced 6.57%	45,171 $1.45 Million
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $61,627 - $79,613	-1,447 Reduced 2.91%	48,350 $2.16 Million
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $57,351 - $92,546	-1,183 Reduced 2.32%	49,797 $2.51 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $626,587 - $977,127	12,457 Added 32.34%	50,980 $4 Million
Q1 2021 May 07, 2021	SELL	$53.8 - $81.53 $8,123 - $12,311	-151 Reduced 0.39%	38,523 $2.2 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $39,509 - $100,202	1,071 Added 2.85%	38,674 $3.24 Million
Q3 2020 Nov 04, 2020	SELL	$23.13 - $38.84 $19,799 - $33,247	-856 Reduced 2.23%	37,603 $1.35 Million
Q2 2020 Aug 12, 2020	BUY	$16.01 - $28.82 $121,579 - $218,859	7,594 Added 24.6%	38,459 $930,000
Q1 2020 May 04, 2020	BUY	$14.2 - $27.98 $11,928 - $23,503	840 Added 2.8%	30,865 $540,000
Q4 2019 Feb 05, 2020	SELL	$14.4 - $19.99 $3,628 - $5,037	-252 Reduced 0.83%	30,025 $523,000
Q3 2019 Nov 08, 2019	SELL	$15.32 - $21.92 $3,232 - $4,625	-211 Reduced 0.69%	30,277 $464,000
Q2 2019 Aug 13, 2019	BUY	$18.5 - $28.14 $26,455 - $40,240	1,430 Added 4.92%	30,488 $633,000
Q1 2019 May 06, 2019	SELL	$17.99 - $24.65 $16,946 - $23,220	-942 Reduced 3.14%	29,058 $675,000
Q4 2018 Feb 13, 2019	SELL	$13.88 - $21.75 $3,206 - $5,024	-231 Reduced 0.76%	30,000 $620,000
Q3 2018 Nov 09, 2018	BUY	$12.46 - $21.74 $239,443 - $417,777	19,217 Added 174.48%	30,231 $657,000
Q2 2018 Aug 08, 2018	BUY	$15.25 - $21.02 $10,629 - $14,650	697 Added 6.76%	11,014 $168,000
Q1 2018 May 07, 2018	BUY	$15.36 - $24.8 $158,469 - $255,861	10,317 New	10,317 $203,000

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$275 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$272 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$230 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$221 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$163 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.77B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account